Literature DB >> 19447535

CKD and risk of hospitalization and death with pneumonia.

Matthew T James1, Hude Quan, Marcello Tonelli, Braden J Manns, Peter Faris, Kevin B Laupland, Brenda R Hemmelgarn.   

Abstract

BACKGROUND: The effects of kidney disease on the risk of hospitalization or death from specific noncardiovascular causes, including pneumonia, are unclear. The objective of this study is to determine the associations between estimated glomerular filtration rate (eGFR) and hospitalization or death with pneumonia. STUDY
DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Community-based study from a Canadian health region of 252,516 participants with 1 or more outpatient serum creatinine measurements from July 1, 2003, to June 30, 2004, who were not receiving dialysis or kidney transplantation. PREDICTOR: eGFR calculated by using the 4-variable Modification of Diet in Renal Disease Study equation. OUTCOMES: Hospitalization with pneumonia or death within 30 days after pneumonia hospitalization. MEASUREMENTS: Cox proportional hazards models adjusted for age, sex, socioeconomic status, and comorbidities with censoring at death, initiation of renal replacement therapy, or emigration.
RESULTS: Lower eGFR was associated with increased risk of hospitalization with pneumonia, although the magnitude of effect varied with age. The risk associated with decreased eGFR was greatest in participants 18 to 54 years old; compared with participants with an eGFR of 60 to 104 mL/min/1.73 m(2), adjusted hazard ratios for hospitalization with pneumonia were 3.23 (95% confidence interval, 2.40 to 4.36) in those with eGFR of 45 to 59 mL/min/1.73 m(2), 9.67 (95% confidence interval, 6.36 to 14.69) for eGFR of 30 to 44 mL/min/1.73 m(2), and 15.04 (95% confidence interval, 9.64 to 23.47) for eGFR less than 30 mL/min/1.73 m(2). Associations became weaker with increasing age, although the graded inverse association between lower eGFR and risk remained for older participants. An age-dependent inverse relationship also was observed between eGFR and risk of death within 30 days of hospitalization with pneumonia. LIMITATIONS: Residual confounding caused by severity of illness or unmeasured comorbidities may be present.
CONCLUSION: The risk of hospitalization and death with pneumonia is greater at lower eGFRs, especially in younger adults. This association may contribute to excess mortality in people with chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447535     DOI: 10.1053/j.ajkd.2009.04.005

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  71 in total

1.  Microbial diagnostics in patients with presumed severe infection in the emergency department.

Authors:  S Hettwer; J Wilhelm; M Schürmann; H Ebelt; D Hammer; M Amoury; F Hofmann; A Oehme; D Wilhelms; A S Kekulé; T Klöss; K Werdan
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-02       Impact factor: 0.840

2.  Analysis of a urinary biomarker panel for incident kidney disease and clinical outcomes.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Martin G Larson; James B Meigs; Ramachandran S Vasan; Caroline S Fox
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

3.  Procalcitonin: diagnostic value in systemic infections in chronic kidney disease or renal transplant patients.

Authors:  Raluca Dumea; Dimitrie Siriopol; Simona Hogas; Irina Mititiuc; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2013-08-30       Impact factor: 2.370

4.  Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Authors:  David M Charytan; Eldrin F Lewis; Akshay S Desai; Larry A Weinrauch; Peter Ivanovich; Robert D Toto; Brian Claggett; Jiankang Liu; L Howard Hartley; Peter Finn; Ajay K Singh; Andrew S Levey; Marc A Pfeffer; John J V McMurray; Scott D Solomon
Journal:  Am J Kidney Dis       Date:  2015-04-29       Impact factor: 8.860

5.  Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage.

Authors:  Yanbei Sun; Lijuan Jiang; Xiaonan Shao
Journal:  Int Urol Nephrol       Date:  2017-09-27       Impact factor: 2.370

6.  Evidence-Based Decision Making 6: Administrative Databases as Secondary Data Source for Epidemiologic and Health Service Research.

Authors:  Tanvir Turin Chowdhury; Brenda R Hemmelgarn
Journal:  Methods Mol Biol       Date:  2021

7.  Chapter 1: Definition and classification of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

8.  Immunosuppressant dose reduction and long-term rejection risk in renal transplant recipients with severe bacterial pneumonia.

Authors:  Chia-Jen Shih; Der-Cherng Tarng; Wu-Chang Yang; Chih-Yu Yang
Journal:  Singapore Med J       Date:  2014-07       Impact factor: 1.858

9.  Improved early risk stratification with cystatin C-based estimated GFR.

Authors:  Meda E Pavkov; Robert G Nelson
Journal:  Am J Kidney Dis       Date:  2014-03-04       Impact factor: 8.860

10.  Developing and validating a multivariable prediction model for in-hospital mortality of pneumonia with advanced chronic kidney disease patients: a retrospective analysis using a nationwide database in Japan.

Authors:  Daisuke Takada; Susumu Kunisawa; Takeshi Matsubara; Kiyohide Fushimi; Motoko Yanagita; Yuichi Imanaka
Journal:  Clin Exp Nephrol       Date:  2020-04-15       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.